‘Maze Runner: The Death Cure’ is delayed for a 2018 premiere following lead actor Dylan O’Brien’s accident on March. 20th Century Fox is cooperating in a safety investigation with WorkSafeBC.
According to the Hollywood Reporter, 20th Century Fox pushed the release date for the upcoming third installment in the ‘Maze Runner’ cinematic trilogy to 2018 following O’Brien’s accident on the filming set. It was originally scheduled to premiere on February 17, 2017.
O’Brien is recuperating from injuries sustained during filming on March 18. His stunt involved being in a harness on top of a moving vehicle. He was pulled from the vehicle and hit by another vehicle. Production was reportedly shut down indefinitely on April 29.
A report from WorkSafeBC, an agency dedicated to workplace health and worker safety in the province of British Columbia, revealed that the 24-year old actor sustained a "concussion, facial fracture and lacerations." Insiders claimed that his injuries were more severe than previously believed.
According to The List, WorkSafeBC stated that the film’s production team was at fault for O’Brien’s accident following an investigation. The report stated that the actor received “minimal instruction” as well as a short lanyard before he went on to perform the stunt in Cache Creek airport in Aschcroft, Canada.
It read, "The change to the action sequence increased the risk of injury as the transition was now between two vehicles that were not connected." WorkSafeBC’s report also revealed that although the stunt was "planned and rehearsed", it underwent changes so the scene could be completed in one sequence instead of two.
20th Century Fox has fully cooperated in the investigation and has until June 15 to respond to the report. The company is also conducting a separate investigation of their own. Chris Petrikin, 20th Century Fox’s Chief Executive and Communications Officer, stated that their primary concern is their leading man’s recovery. He said in a statement, "We have been working with WorkSafeBC to try and correct some inaccuracies in the Inspection Report and appreciate WorkSafe's willingness to discuss our concerns.”
O’Brien starred in ‘Maze Runner: The Death Cure’ and returned to reprise his role in the sequel ‘Maze Runner: The Scorch Trials’. According to Box Office Mojo, the first film grossed $348.31 million worldwide against a $34 million budget while the follow-up earned $312.32 million against a heftier $61 million production budget.
‘Maze Runner: The Death Cure’ is an upcoming science-fiction film intended as the third installment in the ‘Maze Runner’ trilogy based on the young adult novels of the same name authored by James Dashner.


FCC Chair Brendan Carr to Testify Before Senate Commerce Committee Amid Disney-ABC Controversy
Squid Game Finale Boosts Netflix Earnings, But Guidance Disappoints Investors
George Clooney Criticizes Trump’s Tariff Threat, Calls for Film Tax Incentives
Trump Threatens Legal Action Against Disney’s ABC Over Jimmy Kimmel’s Return
Disney’s Streaming Growth Hinges on International Expansion and Local Content
Gulf Sovereign Funds Unite in Paramount–Skydance Bid for Warner Bros Discovery
6 simple questions to tell if a ‘finfluencer’ is more flash than cash
Trump to Pardon Reality Stars Todd and Julie Chrisley After Tax Fraud Conviction
Jazz Ensemble Cancels Kennedy Center New Year’s Eve Shows After Trump Renaming Sparks Backlash
Mexico Probes Miss Universe President Raul Rocha Over Alleged Criminal Links
Trump-Inspired Cantonese Opera Brings Laughter and Political Satire to Hong Kong
Paramount’s $108.4B Hostile Bid for Warner Bros Discovery Signals Major Shift in Hollywood
How Marvel’s Fantastic Four discovered the human in the superhuman
Trump–Kushner Links Raise Concerns as Paramount Pushes $108B Warner Bros Discovery Bid
Oscars 2025: who will likely win, who should win, and who barely deserves to be there 



